EUVIMEDEUVIMED entdecken
Open Access

PGI2 restricts trained ILC2 responses in allergic inflammation

Weisong Zhou, Jian Zhang, Allison E Norlander iD, Daniel P Cook iD, Shinji Toki, Masako Abney, Mark Rusznak, Christopher Thomas, Christian Warren, Bradley W Richmond iD, Katherine Gibson-Corley iD, Ginger L Milne und 2 weitere

The Journal of Immunology · 01.07.2025 · 214 (7) · 1582-1591

DOI: 10.1093/jimmun/vkaf088 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Immunology, online erschienen am 07.05.2025. Verfasst von Weisong Zhou und 13 weiteren Autor:innen. Beteiligte Einrichtung: Division of Allergy, Pulmonary and Critical Care Medicine, Vanderbilt University School of Medicine, Nashville, TN, United States. Hauptthemen laut MEDLINE: Epoprostenol, Lymphocytes, Hypersensitivity, Inflammation. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, NIH HHS, U.S. Department of Veterans Affairs Biomedical Laboratory Research and Development Service.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pulmonary type 2 innate lymphoid cells (ILC2s) exhibit immune memory, termed “trained immunity,” which enhances their activation following exposure to an independent protease-containing allergen. The role of prostaglandin I2 (PGI2), a cyclooxygenase (COX) pathway metabolite, in modulating these trained ILC2 responses remains unclear. PGI2 acts through its G protein–coupled receptor IP. We hypothesized that IP signaling inhibits ILC2 training. To test this hypothesis, we used a mouse ILC2 training model in which we challenged wild-type (WT) and IP knockout (KO) mice with Alternaria alternata extract (Alt) to induce ILC2 activation and training. After a 33-d resting period, ILC2 responses subsided to a homeostatic level. Mice were then intranasally challenged with papain to evaluate responses to an unrelated allergen. IP KO mice displayed significantly heightened ILC2 interleukin (IL)-13 expression and with concomitant increased eosinophilia in the lungs post–papain challenge compared with WT control mice. Notably, neither WT nor IP KO mice challenged with papain only, devoid of ILC2 training, exhibited lung type 2 responses. The augmented type 2 inflammation observed in IP KO mice following both Alt and papain challenges correlated with increased numbers and percentages of IL-13-producing ILC2s and greater mean fluorescence intensity of IL-13 compared with WT mice. Furthermore, RNA sequencing of sorted ILC2s from WT and IP KO mice following Alt-papain challenges revealed heightened activation of immune response pathways and mitochondrial respiratory pathways in IP-deficient ILC2s. These findings reveal an inhibitory role of PGI2 signaling in trained ILC2 responses, emphasizing its pivotal contribution to innate immune responses and allergic inflammation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EpoprostenolLymphocytesHypersensitivityInflammationAnimalsMiceMice, KnockoutImmunity, InnateAlternariaAllergensLungMice, Inbred C57BLPapainImmunologic MemoryInterleukin-13

Stichwörter der Autor:innen

ILC2inflammationlungmouse

Substanzen

EpoprostenolAllergensPapainInterleukin-13

Autor:innen und Institutionen

  • Division of Allergy, Pulmonary and Critical Care Medicine, Vanderbilt University School of Medicine, Nashville, TN, United States.
  • Department of Anatomy, Cell Biology and Physiology, Indiana University School of Medicine, Indianapolis, IN, United States.
  • Department of Internal Medicine, University of Iowa, Iowa City, IA, United States.
  • VA Tennessee Valley Health Care System, U.S. Department of Veterans Affairs, Nashville, TN, United States.
  • Department of Pathology, Microbiology, and Immunology, Vanderbilt University School of Medicine, Nashville, TN, United States.
  • Division of Clinical Pharmacology, Department of Medicine, Vanderbilt University School of Medicine, Nashville, TN, United States.

ORCID-Profile: Allison E Norlander, Daniel P Cook, Bradley W Richmond, Katherine Gibson-Corley, R Stokes Peebles

Förderung

  • NIAID NIH HHS
  • NIH HHS
  • U.S. Department of Veterans Affairs Biomedical Laboratory Research and Development Service
  • Department of Veterans Affairs Biomedical Laboratory Research and Development Service
  • BLRD VA
  • National Institutes of Health

Zitieren

APA

Zhou, W., Zhang, J., Norlander, A. E., Cook, D. P., Toki, S., Abney, M., Rusznak, M., Thomas, C., Warren, C., Richmond, B. W., Gibson-Corley, K., Milne, G. L., Newcomb, D. C., & Peebles, R. S. (2025). PGI2 restricts trained ILC2 responses in allergic inflammation. The Journal of Immunology, 214(7), 1582-1591. https://doi.org/10.1093/jimmun/vkaf088

Vancouver

Zhou W, Zhang J, Norlander AE, Cook DP, Toki S, Abney M, et al. PGI2 restricts trained ILC2 responses in allergic inflammation. The Journal of Immunology. 2025;214(7):1582-1591. doi:10.1093/jimmun/vkaf088

BibTeX
@article{Zhou2025,
  author = {Zhou, Weisong and Zhang, Jian and Norlander, Allison E and Cook, Daniel P and Toki, Shinji and Abney, Masako and Rusznak, Mark and Thomas, Christopher and Warren, Christian and Richmond, Bradley W and Gibson-Corley, Katherine and Milne, Ginger L and Newcomb, Dawn C and Peebles, R Stokes},
  title = {PGI2 restricts trained ILC2 responses in allergic inflammation},
  journal = {The Journal of Immunology},
  year = {2025},
  volume = {214},
  number = {7},
  pages = {1582--1591},
  doi = {10.1093/jimmun/vkaf088}
}
Kostenlos starten →